{{noteTA|G1 = ME}}
{{Medical}} 
{{Infobox drug
| Watchedfields      = changed
| verifiedrevid      = 477164519
| image              = Alprazolam structure.svg
| width              = 135
| alt               = 
| image2             = Alprazolam ball-and-stick model.png
| alt2               = 
| caption           = 

<!-- Clinical data -->
| pronounce          = {{IPAc-en|æ|l|'|p|r|æ|z|ə|l|æ|m}} or {{IPAc-en|æ|l|'|p|r|eɪ|z|ə|l|æ|m}}
| tradename          = Xanax, Xanor, Niravam, others
| Drugs.com          = {{drugs.com|monograph|alprazolam}}
| MedlinePlus        = a684001
| DailyMedID         = Alprazolam
| pregnancy_AU       = C
| pregnancy_AU_comment = 
| pregnancy_category = 
| dependency_liability = High
| addiction_liability = 
| routes_of_administration = [[口服给药|口服]]
| class              = [[Benzodiazepine|Benzodiazepine]]
| ATC_prefix         = N05
| ATC_suffix         = BA12
| ATC_supplemental  = 

<!-- Legal status -->
| legal_AU           = S8
| legal_AU_comment  = 
| legal_BR          = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F -->
| legal_BR_comment  = 
| legal_CA           = Schedule IV
| legal_CA_comment  = 
| legal_DE           = Anlage III
| legal_DE_comment  =  (in doses higher than {{nowrap|1 mg}})
| legal_NZ          = <!-- Class A, B, C -->
| legal_NZ_comment  = 
| legal_UK           = Class C
| legal_UK_comment  = 
| legal_US           = Schedule IV
| legal_US_comment   = 
| legal_EU          = 
| legal_EU_comment  = 
| legal_UN           = P IV
| legal_UN_comment  = 
| legal_status       = Rx-only

<!-- Pharmacokinetic data -->
| bioavailability    = 80–90%
| protein_bound      = 80%
| metabolism         = [[代谢|代谢]]，via [[cytochrome_P450_3A4|cytochrome P450 3A4]]
| metabolites        = Alpha-hydroxyalprazolam, 4-hydroxyalprazolam, beta-hydroxyalprazolam
| onset              = 20~60分钟
| elimination_half-life = 完全释放：11~13小时<br />缓释：11~16小时
| duration_of_action = 完全释放：6小时<br />缓释：11.3小时
| excretion          = [[Kidney|Kidney]]

<!-- Identifiers -->
| CAS_number_Ref     = {{cascite|correct|??}}
| CAS_number         = 28981-97-7
| CAS_supplemental  = 
| PubChem            = 2118
| IUPHAR_ligand      = 7111
| DrugBank_Ref       = {{drugbankcite|correct|drugbank}}
| DrugBank           = DB00404
| ChemSpiderID_Ref   = {{chemspidercite|correct|chemspider}}
| ChemSpiderID       = 2034
| UNII_Ref           = {{fdacite|correct|FDA}}
| UNII               = YU55MQ3IZY
| KEGG_Ref           = {{keggcite|correct|kegg}}
| KEGG               = D00225
| ChEBI_Ref          = {{ebicite|correct|EBI}}
| ChEBI              = 2611
| ChEMBL_Ref         = {{ebicite|correct|EBI}}
| ChEMBL             = 661
| NIAID_ChemDB      = 
| PDB_ligand        = 
| synonyms          = 

<!-- Chemical and physical data -->
| IUPAC_name         = 8-Chloro-1-methyl-6-phenyl-4''H''-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepine
| C                  = 17
| H                  = 13
| Cl                 = 1
| N                  = 4
| SMILES             = Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
| StdInChI_Ref       = {{stdinchicite|correct|chemspider}}
| StdInChI           = 1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3
| StdInChI_comment  = 
| StdInChIKey_Ref    = {{stdinchicite|correct|chemspider}}
| StdInChIKey        = VREFGVBLTWBCJP-UHFFFAOYSA-N
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| sol_units         = 
| specific_rotation = 
}}
'''阿普唑仑'''（商品名：'''Xanax'''）是[[三唑并苯二氮卓类|三唑并苯二氮卓类]]中的中效速效镇静剂，它是与[[三唑|三唑]]环融合的[[苯二氮䓬类|苯二氮卓类]] (BZD)。<ref>{{Cite book|edition=6th|title=Drugs across the spectrum|url=https://www.worldcat.org/oclc/429504239|publisher=Wadsworth, Cengage Learning|date=2010|location=Belmont, CA|isbn=978-0-495-55793-7|oclc=429504239|first=Ray|last=Goldberg}}</ref>它最常用于[[焦虑症|焦虑症]]的短期管理，特别是[[恐慌症|恐慌症]]或[[广泛性焦虑症|广泛性焦虑症]] (GAD)。<ref name="dailymed">{{Cite web |title=XANAX- alprazolam tablet |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=388e249d-b9b6-44c3-9f8f-880eced0239f |website=DailyMed |access-date=2022-06-20}}</ref>其他用途包括治疗化疗引起的恶心，以及其他治疗方法。<ref name="drugs">{{Cite web |title=Alprazolam Monograph for Professionals |url=https://www.drugs.com/monograph/alprazolam.html |website=Drugs.com |language=en |access-date=2022-06-20}}</ref>GAD 改善一般在一周内发生。<ref name="wiley">{{Cite journal |last=Verster |first=Joris C. |last2=Volkerts |first2=Edmund R. |date=2004 |title=Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature |url=https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00003.x |journal=CNS drug reviews |volume=10 |issue=1 |doi=10.1111/j.1527-3458.2004.tb00003.x |issn=1080-563X |pmc=6741717 |pmid=14978513}}</ref><ref>{{Cite book|title=Comprehensive review of psychiatry|url=https://www.worldcat.org/oclc/191317979|publisher=Wolters Kluwer/Lippincott Williams & Wilkins Health|date=2008|location=Philadelphia, PA|isbn=978-0-7817-7176-4|oclc=191317979|first=Rajesh R.|last=Tampi}}</ref>阿普唑仑通常[[口服给药|口服]]。<ref name="drugs" />

常见的副作用包括嗜睡、抑郁、头痛、感觉疲倦、口干和[[失忆症|记忆力问题]]。<ref name="drugs" />一些镇静和疲倦可能会在几天内得到改善。<ref>{{Cite book|edition=5th|title=Principles and practice of psychopharmacotherapy|url=https://www.worldcat.org/oclc/703840461|publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins|date=2011|location=Philadelphia|isbn=1-4511-2502-X|oclc=703840461|first=Stephen R.|last=Marder|first2=Mani N.|last2=Pavuluri}}</ref>由于担心误用，一些人不推荐阿普唑仑作为恐慌症的初始治疗。<ref name="sagepub">{{Cite journal |last=Moylan |first=Steven |last2=Giorlando |first2=Francesco |last3=Nordfjærn |first3=Trond |last4=Berk |first4=Michael |date=2012-03 |title=The role of alprazolam for the treatment of panic disorder in Australia |url=https://journals.sagepub.com/doi/10.1177/0004867411432074 |journal=The Australian and New Zealand Journal of Psychiatry |volume=46 |issue=3 |doi=10.1177/0004867411432074 |issn=1440-1614 |pmid=22391278}}</ref>如果突然减少使用，可能会出现[[药物戒断|戒断]]或反弹症状；<ref name="drugs" />可能需要在数周或数月内逐渐减少[[剂量_(生物化学)|剂量]]。<ref name="wiley" />其他罕见的风险包括[[自杀|自杀]]<ref>{{Cite journal |last=Dodds |first=Tyler J. |date=2017-03-02 |title=Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature |url=https://www.psychiatrist.com/pcc/depression/suicide/prescribed-benzodiazepines-and-suicide-risk/ |journal=The primary care companion for CNS disorders |volume=19 |issue=2 |doi=10.4088/PCC.16r02037 |issn=2155-7780 |pmid=28257172}}</ref><ref>{{Cite journal |last=McCall |first=W. Vaughn |last2=Benca |first2=Ruth M. |last3=Rosenquist |first3=Peter B. |last4=Riley |first4=Mary Anne |last5=McCloud |first5=Laryssa |last6=Newman |first6=Jill C. |last7=Case |first7=Doug |last8=Rumble |first8=Meredith |last9=Krystal |first9=Andrew D. |date=2017-01-01 |title=Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA |url=https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.16030336 |journal=The American Journal of Psychiatry |volume=174 |issue=1 |doi=10.1176/appi.ajp.2016.16030336 |issn=1535-7228 |pmc=5205566 |pmid=27609243}}</ref>和全因死亡风险增加两倍。<ref>{{Cite journal |last=Xu |first=Kevin Y. |last2=Hartz |first2=Sarah M. |last3=Borodovsky |first3=Jacob T. |last4=Bierut |first4=Laura J. |last5=Grucza |first5=Richard A. |date=2020-12-01 |title=Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015 |url=https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2773826 |journal=JAMA network open |volume=3 |issue=12 |doi=10.1001/jamanetworkopen.2020.28557 |issn=2574-3805 |pmc=7726637 |pmid=33295972}}</ref>阿普唑仑与其他苯二氮卓类药物一样，通过[[γ-氨基丁酸A型受体|GABA<sub>A</sub>受体]]起作用。<ref name="drugs" />

阿普唑仑于1971年获得专利，并于1981年在美国获准用于医疗用途。<ref name="drugs" /><ref>{{Cite book|title=Analogue-based drug discovery|url=https://www.worldcat.org/oclc/77601762|publisher=Wiley-VCH|date=2006|location=Weinheim|isbn=978-3-527-60749-5|oclc=77601762|page=536|first=János|last=Fischer|first2=C. R.|last2=Ganellin}}</ref>阿普唑仑是附表IV受控物质，是一种常见的滥用药物。<ref>{{Cite journal |last=Ait-Daoud |first=Nassima |last2=Hamby |first2=Allan Scott |last3=Sharma |first3=Sana |last4=Blevins |first4=Derek |date=2018 Jan/Feb |title=A Review of Alprazolam Use, Misuse, and Withdrawal |url=https://journals.lww.com/journaladdictionmedicine/Abstract/2018/02000/A_Review_of_Alprazolam_Use,_Misuse,_and_Withdrawal.2.aspx |journal=Journal of Addiction Medicine |volume=12 |issue=1 |doi=10.1097/ADM.0000000000000350 |issn=1935-3227 |pmc=5846112 |pmid=28777203}}</ref>它可作为[[通用名药物|通用名药物]]使用。<ref name="dailymed" />2019年，它是美国第41位最常用的处方药，有超过1700万张处方。<ref>{{Cite web |title=The Top 300 of 2019 |url=https://clincalc.com/DrugStats/Top300Drugs.aspx |website=ClinCalc |access-date=2022-06-20}}</ref><ref>{{Cite web |title=Alprazolam - Drug Usage Statistics, ClinCalc DrugStats Database |url=https://clincalc.com/DrugStats/Drugs/Alprazolam |website=ClinCalc |access-date=2022-06-20}}</ref>

== 医疗用途 ==
阿普唑仑主要用于短期治疗焦虑症、恐慌症和[[化学疗法|化疗]]引起的[[恶心|恶心]]。<ref name="wiley" />阿普唑仑适用于治疗成人广泛性焦虑症和恐慌症伴或不伴[[广场恐惧症|广场恐惧症]]。<ref name="dailymed" />FDA标签建议医生应定期重新评估药物的有效性。<ref name="dailymed" />

=== 恐慌症 ===
阿普唑仑可有效缓解中度至重度[[焦虑|焦虑]]和[[恐慌发作|惊恐发作]]。<ref name="dailymed" />然而，自从开发出[[选择性5-羟色胺再摄取抑制剂|选择性5-羟色胺再摄取抑制剂]]以来，它并不是一线治疗。由于对耐受性、依赖性和滥用的担忧，澳大利亚不推荐阿普唑仑用于治疗恐慌症。<ref name="sagepub"/>大多数证据表明，阿普唑仑治疗恐慌症的益处仅持续四到十周。 然而，恐慌症患者已经接受了长达八个月的公开治疗，而没有明显的益处损失。<ref name="dailymed" />

阿普唑仑被世界生物精神病学联合会 (WFSBP) 推荐用于没有[[药物耐受性|耐受]]或[[物质依赖|依赖史]]的恐慌症难治性病例。<ref>{{Cite journal |last=Bandelow |first=Borwin |last2=Zohar |first2=Josef |last3=Hollander |first3=Eric |last4=Kasper |first4=Siegfried |last5=Möller |first5=Hans-Jürgen |last6=World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders |date=2002-10 |title=World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders |url=https://www.tandfonline.com/doi/abs/10.3109/15622970209150621 |journal=The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry |volume=3 |issue=4 |doi=10.3109/15622970209150621 |issn=1562-2975 |pmid=12516310}}</ref>

=== 焦虑症 ===
与抑郁症相关的焦虑对阿普唑仑有反应。临床研究表明，对焦虑症的疗效仅限于 4 个月。<ref name="dailymed" />然而，对阿普唑仑抗抑郁特性的研究很差，只评估了它对抑郁症的短期影响。<ref>{{Cite journal |last=van Marwijk |first=Harm |last2=Allick |first2=Gideon |last3=Wegman |first3=Froukje |last4=Bax |first4=Arjan |last5=Riphagen |first5=Ingrid I. |date=2012-07-11 |title=Alprazolam for depression |url=https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007139.pub2/ |journal=The Cochrane Database of Systematic Reviews |issue=7 |doi=10.1002/14651858.CD007139.pub2 |issn=1469-493X |pmc=6769182 |pmid=22786504}}</ref>在一项研究中，一些长期高剂量服用阿普唑仑的人出现了可逆性抑郁症。<ref>{{Cite journal |last=Lydiard |first=R. B. |last2=Laraia |first2=M. T. |last3=Ballenger |first3=J. C. |last4=Howell |first4=E. F. |date=1987-05 |title=Emergence of depressive symptoms in patients receiving alprazolam for panic disorder |url=https://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.144.5.664 |journal=The American Journal of Psychiatry |volume=144 |issue=5 |doi=10.1176/ajp.144.5.664 |issn=0002-953X |pmid=3578580}}</ref>在美国，阿普唑仑被[[美国食品药品监督管理局|FDA]]批准用于治疗焦虑症（与APA诊断和统计手册[[精神疾病诊断与统计手册|DSM-IV-TR]] 诊断广泛性焦虑症最接近的病症）或短期缓解焦虑症状。在英国，阿普唑仑被推荐用于严重急性焦虑症的短期治疗（2-4周）。<ref name="dailymed" /><ref>{{Cite web |date=2015-03-11 |title=Xanax (alprazolam) |url=http://www.netdoctor.co.uk/medicines/depression/news/a7768/xanax-alprazolam/ |website=Netdoctor |language=en-GB |access-date=2022-06-20}}</ref><ref>{{Cite web |title=Alprazolam |url=https://about.medicinescomplete.com/ |website=MedicinesComplete |language=en-GB |access-date=2022-06-20}}</ref>

==副作用==
[[File:Xanax_2_mg.jpg|thumb]]
可能的副作用包括：
*[[失控_(心理學)|失控]](Disinhibition)<ref name="Michel L, Lang JP 2003 479–85">{{Cite journal | last1 = Michel | first1 = L. | last2 = Lang | first2 = J. P. | trans_title = Benzodiazepines and Forensic Aspects | language = fr | journal = Encephale | year = 2003 | volume = 29 | issue = 6 | pages = 479–485 | pmid = 15029082 | url = http://www.masson.fr/masson/MDOI-ENC-12-2003-29-6-0013-7006-101019-ART2 | title = Benzodiazépines et passage à l'acte criminel | deadurl = no | accessdate = 9 April 2013 | archive-date = 2020-04-14 | archive-url = https://web.archive.org/web/20200414113206/http://www.masson.fr/masson/MDOI-ENC-12-2003-29-6-0013-7006-101019-ART2 }}</ref>
*[[性冲动|性慾]]變化<ref>{{cite web | url = http://www.medicinenet.com/alprazolam-oral/article.htm | title = ALPRAZOLAM – ORAL (Xanax) side effects, medical uses, and drug interactions | accessdate = 2 August 2007 | publisher = Medicinenet.com | archiveurl = https://web.archive.org/web/20070825072108/http://www.medicinenet.com/alprazolam-oral/article.htm | archivedate = 25 August 2007 | deadurl = no}}</ref>
*[[黄疸|黄疸]]（非常罕見）<ref>{{Cite journal | last = Noyes | first = R. | last2 = DuPont | first2 = R. L. | last3 = Pecknold | first3 = J. C. | last4 = Rifkin | first4 = A. | last5 = Rubin | first5 = R. T. | last6 = Swinson | first6 = R. P. | last7 = Ballenger | first7 = J. C. | last8 = Burrows | first8 = G. D. | displayauthors=6 | title = Alprazolam in Panic Disorder and Agoraphobia: Results from a Multicenter Trial. II. Patient Acceptance, Side Effects, and Safety | journal = Archives of General Psychiatry | year = 1988 | volume = 45 | issue = 5 | pages = 423–428 | pmid = 3358644 | doi = 10.1001/archpsyc.1988.01800290037005}}</ref>
*[[幻觉|幻觉]]（罕见）<ref>{{cite web | url = http://alprazolam.drugs.com/ | title = Complete Alprazolam Information | accessdate = 2 August 2007 | website = Drugs.com | archiveurl = https://web.archive.org/web/20070805005458/http://alprazolam.drugs.com/ | archivedate = 5 August 2007 | deadurl = no}}</ref>
*[[口乾|口乾]]（不频繁）<ref>{{Cite journal | last1 = Elie | first1 = R. | last2 = Lamontagne | first2 = Y. | title = Alprazolam and Diazepam in the Treatment of Generalized Anxiety | journal = Journal of Clinical Psychopharmacology | volume = 4 | issue = 3 | pages = 125–129 | year = 1984 | pmid = 6145726 | doi = 10.1097/00004714-198406000-00002}}</ref>
*[[失調|失調]]、[[鬆弛發音|鬆弛發音]]<ref>{{Cite journal | last1 = Cassano | first1 = G. B. | last2 = Toni | first2 = C. | last3 = Petracca | first3 = A. | last4 = Deltito | first4 = J. | last5 = Benkert | first5 = O. | last6 = Curtis | first6 = G. | last7 = Hippius | first7 = H. | last8 = Maier | first8 = W. | last9 = Shera | first9 = D. | last10 = Klerman | first10 = G. | displayauthors = 6 | title = Adverse Effects Associated with the Short-term Treatment of Panic Disorder with Imipramine, Alprazolam or Placebo | journal = European Neuropsychopharmacology | year = 1994 | volume = 4 | issue = 1 | pages = 47–53 | pmid = 8204996 | doi = 10.1016/0924-977X(94)90314-X}}</ref>
*[[自殺意念|自殺意念]]（罕见）<ref name=hori>{{Cite journal | last1 = Hori | first1 = A. | title = Pharmacotherapy for Personality Disorders | journal = Psychiatry and Clinical Neurosciences | year = 1998 | volume = 52 | issue = 1 | pages = 13–19 | pmid = 9682928 | doi = 10.1111/j.1440-1819.1998.tb00967.x}}</ref><ref>{{Cite journal | last1 = Kravitz | first1 = H. M. | last2 = Fawcett | first2 = J. | last3 = Newman | first3 = A. J. | title = Alprazolam and Depression: A Review of Risks and Benefits | journal = Journal of Clinical Psychiatry | year = 1993 | volume = 54 | issue = Supplement | pages = 78–84; discussion 85 | pmid = 8262892}}</ref>
*[[尿瀦留|尿瀦留]]（不频繁）<ref name=ase>{{cite web | url = http://www.drugs.com/alprazolam.html | title = Alprazolam Side Effects, Interactions and Information | accessdate = 2 August 2007 | website = Drugs.com | archiveurl = https://web.archive.org/web/20070819005943/http://www.drugs.com/alprazolam.html | archivedate = 19 August 2007 | deadurl = no}}</ref>
*[[疹|疹]]、[[通氣不足|通氣不足]]（respiratory depression）、[[便秘|便秘]]<ref name=drftb /><ref name=acmirttoadom />
*[[顺行性遗忘症|顺行性遗忘症]]<ref name=Barbee95>{{cite journal | last1 = Barbee | first1 = J. G. | title = Memory, Benzodiazepines, and Anxiety: Integration of Theoretical and Clinical Perspectives | journal = The Journal of Clinical Psychiatry | year = 1993 | volume = 54 | issue = Suppl | pages = 86–97; discussion 98–101 | pmid = 8262893}}</ref> 及[[注意|注意集中]]等問題
*[[睡意|睡意]](Somnolence)、[[暈眩|暈眩]]（dizziness）、[[頭重腳輕|頭重腳輕]]（lightheadedness）、[[疲倦|疲倦]]、不穩定及受損的[[运动协调|运动协调]]、[[眩暈_(醫學)|眩暈]]（vertigo）<ref name=drftb>{{Cite journal | last = Rawson | first = N. S. | last2 = Rawson | first2 = M. J. | title = Acute Adverse Event Signalling Scheme Using the Saskatchewan Administrative Health Care Utilization Datafiles: Results for Two Benzodiazepines | journal = Canadian Journal of Clinical Pharmacology | year = 1999 | volume = 6 | issue = 3 | pages = 159–166 | pmid = 10495368}}</ref><ref name="acmirttoadom">{{cite web | url = http://www.medicinenet.com/alprazolam/article.htm | title = Alprazolam – Complete Medical Information Regarding This Treatment of Anxiety Disorders | publisher = MedicineNet | website = Medicinenet.com | accessdate = 2 August 2007 | archive-date = 2019-03-09 | archive-url = https://web.archive.org/web/20190309191305/https://www.medicinenet.com/alprazolam/article.htm | dead-url = no }}</ref>

=== 異常反應 ===
[[File:Side_effects_of_alprazolam.svg|thumb]].]]
使用阿普唑仑有可能會發生下面的異常反應：
*[[視覺變化|視覺變化]]
*[[醉酒感|醉酒感]]
*[[興奮|興奮]]
*[[侵略_(社會科學)|侵略]]<ref>{{Cite journal | last1 = Rapaport | first1 = M. | last2 = Braff | first2 = D. L. | title = Alprazolam and Hostility | url = https://archive.org/details/sim_american-journal-of-psychiatry_1985-01_142_1/page/146 | journal = American Journal of Psychiatry | year = 1985 | volume = 142 | issue = 1 | page = 146 | pmid = 2857070}}</ref>
*[[憤怒_(情感)|憤怒]]、敵意<ref name="Michel L, Lang JP 2003 479–85" />
*[[震顫|震顫]]（Fasciculations）及[[手震|手震]]<ref>{{Cite journal | last1 = Béchir | first1 = M. | last2 = Schwegler | first2 = K. | last3 = Chenevard | first3 = R. | last4 = Binggeli | first4 = C. | last5 = Caduff | first5 = C. | last6 = Büchi | first6 = S. | last7 = Buddeberg | first7 = C. | last8 = Lüscher | first8 = T. F. | last9 = Noll | first9 = G. | displayauthors = 6 | title = Anxiolytic Therapy with Alprazolam Increases Muscle Sympathetic Activity in Patients with Panic Disorders | journal = Autonomic Neuroscience | year = 2007 | volume = 134 | issue = 1–2 | pages = 69–73 | pmid = 17363337 | doi = 10.1016/j.autneu.2007.01.007}}</ref>
*[[瘋狂|瘋狂]]（Mania）、[[躁動|躁動]]（Psychomotor agitation）、[[肺熱|肺熱]]（hyperactivity）、慌張（restlessness）<ref>{{Cite journal | last1 = Arana | first1 = G. W. | last2 = Pearlman | first2 = C. | last3 = Shader | first3 = R. I. | title = Alprazolam-Induced Mania: Two Clinical Cases | url = https://archive.org/details/sim_american-journal-of-psychiatry_1985-03_142_3/page/368 | journal = American Journal of Psychiatry | year = 1985 | volume = 142 | issue = 3 | pages = 368–369 | pmid = 2857534}}</ref><ref>{{Cite journal | last1 = Strahan | first1 = A. | last2 = Rosenthal | first2 = J. | last3 = Kaswan | first3 = M. | last4 = Winston | first4 = A. | title = Three Case Reports of Acute Paroxysmal Excitement Associated with Alprazolam Treatment | url = https://archive.org/details/sim_american-journal-of-psychiatry_1985-07_142_7/page/859 | journal = American Journal of Psychiatry | volume = 142 | issue = 7 | pages = 859–861 | year = 1985 | pmid = 2861755}}</ref><ref>{{Cite journal | last1 = Reddy | first1 = J. | last2 = Khanna | first2 = S. | last3 = Anand | first3 = U. | last4 = Banerjee | first4 = A. | title = Alprazolam-Induced Hypomania | journal = Australia and New Zealand Journal of Psychiatry | year = 1996 | volume = 30 | issue = 4 | pages = 550–552 | pmid = 8887708 | doi = 10.3109/00048679609065031}}</ref>

=== 食品和藥物相互作用 ===
阿普唑崙的代謝主要是通過[[CYP3A4|CYP<sub>3</sub>A<sub>4</sub>]]進行<ref name="Otani-2003">{{Cite journal | last1 = Otani | first1 = K. | title = Cytochrome P450 3A4 and Benzodiazepines | language = ja | journal = Seishin Shinkeigaku Zasshi | volume = 105 | issue = 5 | pages = 631–642 | year = 2003 | pmid = 12875231}}</ref>，結合[[CYP3A4|CYP<sub>3</sub>A<sub>4</sub>]]临床上，抑製劑諸如[[西咪替丁|西咪替丁]]、[[紅黴素|紅黴素]]、[[氟西汀|氟西汀]]、[[氟伏沙明|氟伏沙明]]、[[伊曲康唑|伊曲康唑]]、[[酮康唑|酮康唑]]、[[奈法唑酮|奈法唑酮]]（Nefazodone）、[[丙氧芬|丙氧芬]]（Propoxyphene）、[[利托那韋|利托那韋]]（Ritonavir）等可以延緩阿普唑崙的[[肝清除率|肝清除率]]，但是這可能導致阿普唑崙在人体内部的的過度積纍<ref>{{Cite journal | last1 = Dresser | first1 = G. K. | last2 = Spence | first2 = J. D. | last3 = Bailey | first3 = D. G. | title = Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition | journal = Clinical Pharmacokinetics | year = 2000 | volume = 38 | issue = 1 | pages = 41–57 | pmid = 10668858 | doi = 10.2165/00003088-200038010-00003}}</ref>，如此很有可能會導致其不良反應更加的惡化<ref name=cpoati>{{cite journal | last1 = Greenblatt | first1 = D. J. | last2 = Wright | first2 = C. E. | title = Clinical Pharmacokinetics of Alprazolam. Therapeutic Implications | journal = Clinical Pharmacokinetics | year = 1993 | volume = 24 | issue = 6 | pages = 453–471 | doi = 10.2165/00003088-199324060-00003 | pmid = 8513649}}</ref><ref>{{Cite journal | last1 = Wang | first1 = J. S. | last2 = Chase | first2 = C. L. | title = Pharmacokinetics and Drug Interactions of the Sedative Hypnotics | journal = Psychopharmacological Bulletin | year = 2003 | volume = 37 | issue = 1 | pages = 10–29 | pmid = 14561946 | doi = 10.1007/BF01990373 | url = http://www.medworksmedia.com/psychopharmbulletin/pdf/12/010-029_PB%20W03_Wang_final.pdf | archiveurl = https://web.archive.org/web/20070709230745/http://www.medworksmedia.com/psychopharmbulletin/pdf/12/010-029_PB%20W03_Wang_final.pdf | archivedate = 2007-07-09 | format = PDF}}</ref>。

==參考資料==
{{reflist}}

==外部連結==
{{Commonscat|Alprazolam|阿普唑仑}}
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Alprazolam U.S. National Library of Medicine: Drug Information Portal – Alprazolam] {{Wayback|url=http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Alprazolam |date=20140306190055 }}
* [http://www.erowid.org/pharms/alprazolam/alprazolam.shtml Erowid Alprazolam (Xanax) Research] {{Wayback|url=http://www.erowid.org/pharms/alprazolam/alprazolam.shtml |date=20140308002818 }}
*[http://www.ccpp.com.tw/_tw/01_product/02_detail.aspx?AID=367 神經系統-鎮靜、催眠、精神安定劑-Amprazo(柔安)] {{Wayback|url=http://www.ccpp.com.tw/_tw/01_product/02_detail.aspx?AID=367 |date=20140306191835 }}

{{致幻剂}}
{{苯二氮䓬类药物}}
{{Anxiolytics}}
{{精神药品品种目录}}

{{Authority control}}
[[Category:苯二氮䓬类药物|Category:苯二氮䓬类药物]]
[[Category:有机氯化合物|Category:有机氯化合物]]
[[Category:三唑|Category:三唑]]
[[Category:輝瑞產品|Category:輝瑞產品]]
[[Category:抗焦慮藥|Category:抗焦慮藥]]
[[Category:氯代芳烴|Category:氯代芳烴]]